Digital PCR (dPCR) and Real-time PCR (qPCR) Market Key Players, Size, Share, Demands, Trend, Growth Rate and Forecasts to 2028

The global Digital PCR and Real-time PCR Market is consolidated market. The market is estimated to grow to USD 12.4 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 7.8%. The growth of this market is due to factors such as the rising infectious diseases and genetic disorders, continuous advancements in PCR technologies, and increasing investments. However, high instrument costs-especially that of dPCR-and the technical limitations of PCR are restraining market growth.

Get a Free Sample Copy of the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1088567

Digital PCR (dPCR) and Real-time PCR (qPCR) are two advanced molecular biology techniques used for nucleic acid quantification and analysis. Both techniques are used for the detection and measurement of DNA and RNA molecules in various applications, including research, clinical diagnostics, and forensic analysis.

The global dPCR and qPCR market has been growing steadily in recent years, driven by factors such as the increasing demand for accurate and sensitive molecular diagnostics, the rising prevalence of infectious diseases, and the growing use of these techniques in research and development activities.

Prominent players in the global digital PCR (dPCR) and real-time PCR (qPCR) market are, Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies, Inc. (US), Becton, Dickinson and Company (US), Takara Bio Inc. (Japan), Danaher Corporation (US), Eppendorf (Germany), Promega Corporation (US), Merck KGaA (Germany), QIAGEN (Germany), BioMérieux (France), Meridian Bioscience (US), Quidel Corporation (US), Enzo Biochem, Inc. (US), Stilla (France), Standard BioTools (US), ENDRESS+HAUSER Group Services AG (ENDRESS+HAUSER) (Switzerland), JN Medsys (Singapore), BIONEER CORPORATION (South Korea), ELITech Group (France), QuantaBio (US), Sacace Biotechnologies Srl (Italy), Bio Molecular Systems (Australia), Biomeme, Inc. (US), Kyratec (Australia), LGC Bioresearch Technologies (England), Antylia Scientific (US), and Genome Diagnostics Pvt. Ltd. (India). These companies manufacture and distribute a range of dPCR and qPCR systems, reagents, and accessories for various applications.

The dPCR market is expected to grow at a faster rate than qPCR due to its higher sensitivity, greater precision, and ability to detect low-frequency mutations and variants in samples. However, qPCR remains the more widely used technique, as it is simpler, faster, and more affordable.

The dPCR and qPCR market is also influenced by trends such as the increasing use of these techniques in liquid biopsy and oncology research, the adoption of automation and robotics for high-throughput analysis, and the development of portable and user-friendly systems for point-of-care diagnostics.

Direct Purchase of the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1088567

While the dPCR and qPCR market is expected to continue growing in the coming years, it may face challenges such as the high cost of dPCR systems and the need for standardization and validation of these techniques in clinical settings.

+ 1 347 333 3771
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.